Medline Inc. (MDLN)
Health Care · Medical Supplies & Distribution · NASDAQ
Medline is a leading global manufacturer and distributor of medical supplies and clinical solutions serving healthcare providers across the care continuum.
What Medline Inc. does
Medline is a manufacturer and distributor of medical supplies and clinical solutions. The company provides a broad range of products to healthcare providers, focusing on medical-surgical supplies and clinical programs across the continuum of care.
Themes: healthcare supply chain, medical devices
Fundamentals
- Price$36.26 as of 2026-10-09 close
- Market cap$47.7B as of 2026-08-03 (share count; price 2026-10-09)
- P/E43.00 as of 2026-10-09
- Net margin+4.1% FY2025, SEC XBRL
- Gross margin+26.4% FY2025, SEC XBRL
- ROE+10.8% FY2025, SEC XBRL
- Debt / equity1.09 as of 2026-09-03
- Revenue growth (YoY)+11.6% as of 2026-09-03
- Revenue CAGR (3y)+10.6% SEC XBRL
- Beta0.61 as of 2026-09-03
- Last reported earnings2026-08-05 SEC EDGAR Form 8-K (Item 2.02)
How MDLN compares in its sector
- price-to-earnings ratiomiddle range 185 covered Health Care peers, as of 2026-10-09
- net profit marginmiddle range 430 covered Health Care peers, as of 2026-09-03
- operating marginmiddle range 417 covered Health Care peers, as of 2026-09-03
- gross marginbottom 25% 189 covered Health Care peers, as of 2026-09-03
- return on equitytop 25% 510 covered Health Care peers, as of 2026-09-03
- 3-year revenue CAGRmiddle range 402 covered Health Care peers
- free cash flow (absolute dollars, latest fiscal year)top 10% 494 covered Health Care peers, as of FY2025
Position among covered Health Care companies that report each metric (minimum 5 peers). A relative position within our covered catalog — not a valuation, quality, or investment judgment. A higher percentile is simply a higher value (for P/E, more expensive on earnings — never "better"). Informational only.
Top 10 scores & list membership
MDLN is not currently in any published Top 10 list. Its scores are below.
Top 10 score
42.2 #1120 of 1,383 scored · #131 of 153 in Health Care
Growth 62nd (3-year revenue CAGR 10.6%, revenue growth year over year 11.6%) and trend 52nd (no clear trend either way (ADX below 20)); weakest is capital return (18th, consecutive years of dividend increases 0 years).
Scores as of 9 Oct 2026. Each bar is a percentile: how this company ranked against every company the score ranked, 0–100. A list is a published formula and its output, not a recommendation. Method version 4.
How Medline Inc. looks technically
Medline Inc. (MDLN): there is no clear trend right now — the price is choppy (ADX, a 0–100 trend-strength gauge, is 17, below the 25 that marks a real trend). Momentum is neutral — its 14-day RSI (a 0–100 momentum gauge) is 60, neither overbought (above 70) nor oversold (below 30). It just made a new 20-day high, its first since 2026-09-04, pushing above its recent trading range.
Trend
8
| Distance from the 200-day | not enough price history yet — needs 200 trading sessions | n/a |
|---|---|---|
| 50-day moving average | its average price over the last 50 trading days — a short-term trend line — is $34.95 | $34.95 |
| 200-day moving average | not enough price history yet — needs 200 trading sessions | n/a |
| Swing structure | each recent peak has been lower than the one before it and each dip deeper — the pattern chart-watchers call a downtrend, which describes where price has already been and not where it goes next | lower highs and lower lows |
| Last swing turn | its last significant turn was a swing low 21 calendar days ago — the swings before that are what the structure reading is measured on | 21 sessions |
| Wave structure | its recent swings can be read as a completed three-part downward correction — a pullback in the A-B-C shape Elliott-wave chartists use; the labelling fails if price closes below 31.49. It is the only labelling that fits, though not with textbook proportions, and it describes the swings already printed, not what comes next. | possible three-wave downward correction, complete (atypical proportions) |
| Since the 50/200 cross | not enough price history yet — needs 200 trading sessions | n/a |
| Trend strength (14-day ADX) | there is no clear trend right now — the price is choppy (ADX, a 0–100 trend-strength gauge, is 17, below the 25 that marks a real trend) | 17.2 |
Momentum
3
| 14-day RSI | momentum is neutral — its 14-day RSI (a 0–100 momentum gauge) is 60, neither overbought (above 70) nor oversold (below 30) | 60.4 |
|---|---|---|
| Position in its 14-day range | it is trading near the top of its 14-day range ($32.38 to $36.88) — its "stochastic" reading is 86 out of 100, where 0 would mean closing exactly at the 14-session low and 100 exactly at the high. This measures WHERE the price sits inside its recent range, which is a different question from the RSI beside it: RSI is a momentum gauge, measuring how FAST the price has been moving, so a stock can drift quietly to the bottom of its range with an ordinary RSI, or fall sharply and still sit in the middle. It has been climbing within that range over the last few sessions. | 86.3 |
| Since the MACD crossed zero | MACD, a trend-momentum gauge, is in positive territory (momentum leaning bullish) | 14 sessions |
Range
7
| Since a 20-day breakout | it just made a new 20-day high, its first since 2026-09-04, pushing above its recent trading range | 1 session |
|---|---|---|
| Since a 55-day breakout | it made a new 55-day low about 16 trading days ago | 16 sessions |
| All-time high | its highest closing price on record is $50.88 (set on 2026-02-25) | $50.88 |
| Given back of the 52-week move | not available for this company yet | n/a |
| Nearest price level | not enough price history yet — needs 252 trading sessions | n/a |
| All-time low | its lowest closing price on record is $31.49 (set on 2026-09-18) | $31.49 |
| Above the all-time low | it is 15.1% above its all-time low | +15.2% |
Volatility
4
| Band width vs its own 6 months | day-to-day price swings are about average versus its own recent 6-month history | 43rd percentile |
|---|---|---|
| Typical daily range | in a typical session it travels about $1.19 between its high and its low — about 3.3% of its price. That is its "average true range" over the last 14 sessions, which also counts the distance from the previous close, so a day that opens well away from yesterday counts as the large move it was | $1.19 |
| Bollinger bands (20-day, ±2σ) | most of its recent trading has stayed between about $31.40 and $37.16 — the "Bollinger bands", a range drawn two standard deviations either side of its 20-day average price, which widens when the stock gets more volatile and narrows when it settles | $31.40 – $34.28 – $37.16 |
| Typical daily range (% of price) | its price moves about 3.3% in a typical session — about typical for the companies we cover. This is the average gap between a session's high and low over the last 14 sessions, counting overnight moves, expressed against the current price so it can be compared with companies trading at any price | 3.3% |
Volume
1
| Volume vs its 30-day average | trading volume is about normal versus its 30-day average | 0.61× |
|---|
Analyst
2
| Change in the average price target | analysts' average price target is unchanged from the prior reading | 0.0% |
|---|---|---|
| Change in the consensus rating | the analyst consensus rating is unchanged since the prior reading | unchanged |
Candlestick patterns
2
| Since a doji | 6 sessions ago it opened and closed at almost the same price after trading through a wider range — a "doji", the classic picture of buyers and sellers finishing the session level | 6 sessions ago |
|---|---|---|
| Since a bullish engulfing | 1 session ago it opened below the previous session's close and finished above that session's open — a "bullish engulfing" pair, where one up day more than undid the down day before it | 1 session ago |
Price gaps
2
| Gap at the open | it opened on 2026-10-09 0.3% below the previous session's close — an overnight gap, the part of the move that happened while the market was shut, and traded back through that level before the close | -0.3% |
|---|---|---|
| Open gap | it gapped 11.3% below the previous close 46 sessions ago and has not traded back through the level it left behind at 42.04 — an "unfilled gap", which describes a price range no trade has since crossed and is not a forecast that it will be crossed | -11.3% |
Price streaks
1
| Closing streak | it has closed higher 2 sessions in a row, a +2.28% move over the run — an unbroken run of up days, which describes what has already happened and says nothing about the next session | 2 sessions up |
|---|
Relative strength
4
| vs market, 1 month | over the past 1 month this stock beat the market by 4.4 percentage points (the stock gained 6.5% while the market gained 2.1%) | +4.4% |
|---|---|---|
| vs market, 3 months | over the past 3 months this stock lagged the market by 14.8 percentage points (the stock lost 11.2% while the market gained 3.6%) | -14.8% |
| vs market, 6 months | over the past 6 months this stock lagged the market by 35.1 percentage points (the stock lost 20.6% while the market gained 14.5%) | -35.1% |
| vs market, 12 months | not available for this company yet | n/a |
Signal agreement
2
| Bullish technical signals | 2 of the 7 technical signals we can compute for it are currently in a bullish state: a fresh 20-day high, MACD momentum is positive — these describe past price behaviour, not a forecast | 2 of 7 |
|---|---|---|
| Bearish technical signals | 2 of the 7 technical signals we can compute for it are currently in a bearish state: lagging the market over 6 months, near the top of its 14-day range (overbought) — these describe past price behaviour, not a forecast | 2 of 7 |
Trend (Ichimoku cloud)
1
| Vs the Ichimoku cloud | trading inside the Ichimoku cloud — a band drawn from where its own highs and lows sat up to 2026-09-02 and projected forward over today's price, the zone traders read as unresolved — neither side has established a trend, and the band is where that gets settled. The band itself is moderate, spanning 5.9% of the share price. | 0.0% |
|---|
Volume-weighted price
2
| Vs this year’s average price paid | the price is 8% below the average price paid so far this year, so the typical buyer over that stretch is under water. That average is $39.26 — a volume-weighted average of daily closes over 184 sessions, not a true tick-by-tick VWAP. | -7.6% |
|---|---|---|
| Vs the average paid since it last reported | the price is 5% above the average price paid since it last reported on 2026-08-05 (its 10-Q), so the typical buyer over that stretch is showing a gain. That average is $34.58 — a volume-weighted average of daily closes over 47 sessions, not a true tick-by-tick VWAP. | +4.9% |
Double bottom, bullish — broke out · entry $35.64 · 35 sessions in
Wave structure
Its recent swings can be read as a three-part downward correction — the A-B-C shape chartists use for a pullback — now complete.
This labelling fails — stops being a possible reading at all — if it closes below $31.49.
It is the only labelling that fits these swings, though its proportions are not the textbook ones.
This reading has stood for 11 trading days, since 2026-09-25.
Read from daily closes as of 2026-10-09.
An Elliott-wave count describes the swings already printed and the level that would disprove it. It is not a forecast, a target, or advice.
Screens: Broke out to a new 20-day high · trendless / choppy (low ADX) · At the top of its 14-day range (stochastic above 80) · Trading inside the Ichimoku cloud | Learn: adx · rsi · breakout
Based on daily closing prices as of 2026-10-09. Describes past price behavior only — informational, not financial advice.
Analyst consensus
- Consensus ratingBuy (1.56 mean, 1=Strong Buy…5=Strong Sell) — 26 analysts
- Mean price target$44.42 range $34.00 – $55.00; median $45.00
Analyst estimates, as of 2026-10-10. These are third-party analyst opinions and price targets, aggregated — not a recommendation, prediction, or advice from stocks-llm. Informational only.
Analyst EPS estimate for MDLN
- Consensus EPS estimate$0.3463 next reporting period, as of 2026-10-10
- Estimate change, 30 days-$0.0008 (-0.2%) from $0.3471, on 2026-09-05, 35-day window
- Readings revised upward13% of 8 comparable readings
The consensus estimate for the next reporting period, and how it has moved between readings of that SAME period. A change is measured only between readings estimating one period — when a company reports, the consensus moves to the next quarter and the two numbers are not comparable. Informational only, not a forecast and not advice.
Key risks (from latest filing)
["Exposure to significant debt obligations (e.g., senior secured and unsecured notes)","Reliance on maintaining operational and distribution scale within the competitive healthcare supply chain industry"]
Insider activity (SEC Form 4)
0 open-market purchases and 11 open-market sales by insiders in the last 90 days, of which we have read Form 4 filings through 2026-10-05. The 6 days since 2026-10-05 have not been checked yet.
- Last 30 days · read to 2026-10-050 buys · 5 sells ($722M) — 1 selling insider
- Last 90 days · read to 2026-10-050 buys · 11 sells ($880M) — 1 selling insider
- Last 180 days · read to 2026-10-051 buy ($170750) · 25 sells ($4.5B) — 1 buying, 5 selling insiders
Activity heuristic: net selling (a transparent product heuristic from the counts above, not a prediction or advice)
Most recent open-market transaction: 2026-10-06. Based on Form 4 filings read through 2026-10-05; anything filed since is not yet included.
View full insider trading history → View SEC Form 3/4/5 filingsAsk about MDLN's insider activity →
Only open-market purchases (SEC code P) and sales (code S) are counted here. Option exercises, vesting/awards, gifts, and shares withheld for taxes are excluded — they are compensation or mechanical, not open-market conviction. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan) and are not necessarily bearish; open-market buying is not a recommendation to buy. Informational only — not financial advice.
Institutional ownership (13F)
6 institutional 13F filers reported holding MDLN as of 2026-06-30 (quarter-end position, filed within 45 days).
- Distinct 13F filers 6
- Reported shares held 87,544,724
- Reported value $3,452,763,933
reported quarterly holdings change (2026-03-31 → 2026-06-30): 1 new, 3 increased, 2 decreased, 1 exited. Change counts cover only managers that filed 13F reports in BOTH quarters, derived between two quarter-end snapshots — not same-day trades; a single manager is never said to have "bought" or "sold".
Institutional holdings are quarter-end long positions reported on SEC Form 13F-HR, filed up to 45 days after the quarter ends — they are delayed, are not real-time trades, exclude short positions and most non-US securities, and are not investment advice. Any increase/decrease is a reported change between two quarterly snapshots, not a same-day purchase or sale. These are quarter-end snapshots from the 13F filings on SEC EDGAR, filed within 45 days — not real-time, and any change is a difference between two quarterly reports, not a same-day trade. Informational only — not financial advice.
Ask about MDLN's institutional holders → See what each manager we track holds →
Short interest (FINRA)
MDLN had 41,309,561 shares of reported short interest as of the 2026-09-15 FINRA settlement date (delayed, bi-monthly; not real-time).
Short interest as a percent of shares outstanding is not shown for MDLN because we do not hold a verified share count to divide it by. The reported figures above are unaffected.
- Reported short interest (shares) 41,309,561
- Prior settlement (shares) 39,481,289
- Reported change 4.63%
- Days to cover (reported) 6.43
Reported to FINRA as of the 2026-09-15 settlement date. Short interest is reported to FINRA and published on a delayed, bi-monthly schedule (as of a settlement date, disseminated roughly eight business days later) — it is NOT real-time, does not cover every venue or all US trading, and is not a short-squeeze prediction or investment advice. Days-to-cover is the value FINRA reports; percent of float is not shown because the source file carries no share-count denominator — where a percent appears it is of shares OUTSTANDING, the larger base, and is therefore a floor on percent of float. Informational only — not financial advice.
Competitors & peers
- Cardinal Health (CAH)
- McKesson Corporation (MCK)
- Owens & Minor (OMI)
- Henry Schein (HSIC)
AI-enriched competitor set. Linked names are companies covered by stocks-llm; other named peers are shown for reference only.
Compare MDLN vs…
Medline Inc. is found in…
Frequently asked questions
What does Medline Inc. (MDLN) do?
Medline is a manufacturer and distributor of medical supplies and clinical solutions. The company provides a broad range of products to healthcare providers, focusing on medical-surgical supplies and clinical programs across the continuum of care.
What sector is Medline Inc. (MDLN) in?
Medline Inc. (MDLN) is classified in the Health Care sector. Its industry is Medical Supplies & Distribution. It trades on NASDAQ.
Who are Medline Inc.'s (MDLN) competitors?
Notable peers of Medline Inc. (MDLN) include Cardinal Health, McKesson Corporation, Owens & Minor and Henry Schein. This peer set is informational only — not financial advice.
Is Medline Inc. (MDLN) overbought or oversold right now?
Medline Inc. (MDLN) is currently neither overbought nor oversold — its 14-day RSI (a 0–100 momentum gauge) is 60, in the neutral middle (as of 2026-10-09). RSI describes recent price momentum, not a forecast — informational only, not financial advice.
Where does stocks-llm's data on MDLN come from?
Fundamentals come from SEC XBRL company filings for the figures marked with a fiscal year, and market data, as of 2026-09-03 for the rest; prices are market data, as of 2026-09-03; company filings and profile facts come from SEC EDGAR. All figures are delayed daily-close data shown with their as-of date — informational only, not financial advice.
Fundamentals: SEC XBRL company filings for the figures marked with a fiscal year, and market data, as of 2026-09-03 for the rest. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-10-09.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date.